Champions Oncology, Inc. Q2 FY2024 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2024 Q2 Call date: 2023-12-12 Concluded

Quarter scorecard

Revenue

$11.57M

-19% YoY

Diluted EPS

$-0.15

Net income

-$2.07M

Pharmacology Services $10.88M

-19.3%

Product And Service Other $697,000

-4.7%

Personalized Oncology Services $0

-100%

Buybacks (derived)

$32,000